FDA Adverse Event Injury Summary report: N

SURESCAN

MDR report key: 7280930 · Received February 19, 2018

Report

Report Number
3004209178-2018-03573
Event Type
Injury
Date Received
February 19, 2018
Date of Event
February 1, 2018
Report Date
May 31, 2018
Manufacturer
MEDTRONIC PUERTO RICO OPERATIONS CO.
Product Code
LGW
UDI-DI
00643169109483
PMA / PMN Number
P840001
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

PRODUCT ID: 3998, LOT# V013787, IMPLANTED: (B)(6) 2007, EXPLANTED: (B)(6) 2018, PRODUCT TYPE: LEAD. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

INFORMATION WAS RECEIVED FROM A PATIENT REGARDING THEIR NEUROSTIMULATOR (INS) THAT WAS IMPLANTED FOR NON-MALIGNANT PAIN. IT WAS REPORTED THAT PATIENT WAS NOT FEELING WHAT HE USED TO FEEL BEFORE, HE WAS NOT FEELING STIM. THEY HAD TRIED CHANGING PROGRAMS/GROUPS/INTENSITY AND WAS STILL NOT FEELING STIM AT ALL. CALLER WANTED TO MEET WITH A MANUFACTURER REP FOR REPROGRAMMING. IT WAS CONFIRMED THOROUGH THE PATIENT PROGRAMMER THAT PATIENT'S THERAPY WAS ON. CALLER WAS REDIRECTED TO THEIR HCP. AN EXACT DATE OF WHEN THE EVENT OCCURRED WAS NOT PROVIDED. PATIENT REPORTED MAYBE IN (B)(6). NO FURTHER COMPLICATIONS WERE REPORTED/ANTICIPATED.

Description of Event or Problem · 1

ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT. THE PATIENT REPORTED THAT THE CIRCUMSTANCES THAT LED TO NOT FEELING STIMULATION WAS THAT THE PADDLES NEEDED REPLACED. THE PATIENT REPORTED THAT HE MET WITH A MANUFACTURER¿S REPRESENTATIVE (REP). THE PATIENT REPORTED THAT HE WAS NOW FEELING STIMULATION AND HAD SURGERY TO REMOVE THE OLD AND PUT IN NEW PADDLES. NO FURTHER COMPLICATIONS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
123286 SURESCAN STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF LGW MEDTRONIC PUERTO RICO OPERATIONS CO. 97714 00643169109483

Patients

Seq Age Sex Outcome Treatment
1 61 YR Required Intervention